Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236103 · ClinicalTrials.gov registry record · NA
AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 900
- Enrollment target
NCT03236103: Completed NA study, sponsored by Mayo Clinic.
NCT03236103 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 900 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03236103, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
Study Summary
The investigators are doing this research to investigate whether multifaceted preventive measures for newly hospitalized ventricular assist device (VAD) patients will reduce the Acute Kidney Injury (AKI) occurrence rate, progression and associated complications
Interventions
- OTHER Clinical Recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2017-05-19 |
| Est. Completion | 2019-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236103
The ClinicalTrials.gov registry entry for NCT03236103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Recommendations is the first listed.
NCT03236103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03236103 about?
NCT03236103 is a clinical study titled "AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.". The investigators are doing this research to investigate whether multifaceted preventive measures for newly hospitalized ventricular assist device (VAD) patients will reduce the Acute Kidney Injury (AKI) occurrence rate, progression and associated complications
What is the current status of trial NCT03236103?
This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2017-05-19. Estimated completion is 2019-04-08.
What interventions are being tested in trial NCT03236103?
The interventions under investigation include: Clinical Recommendations (OTHER).
Who is sponsoring clinical trial NCT03236103?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.